Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients With Platinum-refractory Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07529873 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07529873
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2030-04-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.